-
Data-driven Fair Resource Allocation For Novel Emerging Epidemics: A COVID-19 Convalescent Plasma Case Study
Authors:
Maryam Akbari-Moghaddam,
Na Li,
Douglas G. Down,
Donald M. Arnold,
Jeannie Callum,
Philippe Bégin,
Nancy M. Heddle
Abstract:
Epidemics are a serious public health threat, and the resources for mitigating their effects are typically limited. Decision-makers face challenges in forecasting the supply and demand for these resources as prior information about the disease is often not available, the behaviour of the disease can periodically change (either naturally or as a result of public health policies) and can differ by g…
▽ More
Epidemics are a serious public health threat, and the resources for mitigating their effects are typically limited. Decision-makers face challenges in forecasting the supply and demand for these resources as prior information about the disease is often not available, the behaviour of the disease can periodically change (either naturally or as a result of public health policies) and can differ by geographical region. Randomized controlled trials (RCTs) using scarce resources such as blood products as a randomized intervention are affected by epidemics. In this work, we discuss a model that is suitable for short-term real-time supply and demand forecasting during emerging outbreaks. We consider a case study of demand forecasting and allocating scarce quantities of COVID-19 Convalescent Plasma (CCP) in an international multi-site RCT involving multiple hospital hubs across Canada (excluding Québec). We propose a data-driven mixed-integer programming (MIP) resource allocation model that assigns available resources to maximize a notion of fairness among the resource-demanding entities. Numerical results from applying our MIP model to the case study suggest that our approach can help balance the supply and demand of limited products such as CCP and minimize the unmet demand ratios of the demand entities. We analyze the sensitivity of our model to different allocation settings and show that our model assigns equitable allocations across the entities.
△ Less
Submitted 20 January, 2023; v1 submitted 24 June, 2021;
originally announced June 2021.
-
Demand Forecasting for Platelet Usage: from Univariate Time Series to Multivariate Models
Authors:
Maryam Motamedi,
Jessica Dawson,
Na Li,
Douglas G. Down,
Nancy M. Heddle
Abstract:
Platelet products are both expensive and have very short shelf lives. As usage rates for platelets are highly variable, the effective management of platelet demand and supply is very important yet challenging. The primary goal of this paper is to present an efficient forecasting model for platelet demand at Canadian Blood Services (CBS). To accomplish this goal, four different demand forecasting m…
▽ More
Platelet products are both expensive and have very short shelf lives. As usage rates for platelets are highly variable, the effective management of platelet demand and supply is very important yet challenging. The primary goal of this paper is to present an efficient forecasting model for platelet demand at Canadian Blood Services (CBS). To accomplish this goal, four different demand forecasting methods, ARIMA (Auto Regressive Moving Average), Prophet, lasso regression (least absolute shrinkage and selection operator) and LSTM (Long Short-Term Memory) networks are utilized and evaluated. We use a large clinical dataset for a centralized blood distribution centre for four hospitals in Hamilton, Ontario, spanning from 2010 to 2018 and consisting of daily platelet transfusions along with information such as the product specifications, the recipients' characteristics, and the recipients' laboratory test results. This study is the first to utilize different methods from statistical time series models to data-driven regression and a machine learning technique for platelet transfusion using clinical predictors and with different amounts of data. We find that the multivariate approaches have the highest accuracy in general, however, if sufficient data are available, a simpler time series approach such as ARIMA appears to be sufficient. We also comment on the approach to choose clinical indicators (inputs) for the multivariate models.
△ Less
Submitted 23 December, 2022; v1 submitted 6 January, 2021;
originally announced January 2021.
-
A decision integration strategy for short-term demand forecasting and ordering for red blood cell components
Authors:
Na Li,
Fei Chiang,
Douglas G. Down,
Nancy M. Heddle
Abstract:
Blood transfusion is one of the most crucial and commonly administered therapeutics worldwide. The need for more accurate and efficient ways to manage blood demand and supply is an increasing concern. Building a technology-based, robust blood demand and supply chain that can achieve the goals of reducing ordering frequency, inventory level, wastage and shortage, while maintaining the safety of blo…
▽ More
Blood transfusion is one of the most crucial and commonly administered therapeutics worldwide. The need for more accurate and efficient ways to manage blood demand and supply is an increasing concern. Building a technology-based, robust blood demand and supply chain that can achieve the goals of reducing ordering frequency, inventory level, wastage and shortage, while maintaining the safety of blood usage, is essential in modern healthcare systems. In this study, we summarize the key challenges in current demand and supply management for red blood cells (RBCs). We combine ideas from statistical time series modeling, machine learning, and operations research in develo** an ordering decision strategy for RBCs, through integrating a hybrid demand forecasting model using clinical predictors and a data-driven multi-period inventory problem considering inventory and reorder constraints. We have applied the integrated ordering strategy to the blood inventory management system in Hamilton, Ontario using a large clinical database from 2008 to 2018. The proposed hybrid demand forecasting model provides robust and accurate predictions, and identifies important clinical predictors for short-term RBC demand forecasting. Compared with the actual historical data, our integrated ordering strategy reduces the inventory level by 40% and decreases the ordering frequency by 60%, with low incidence of shortages and wastage due to expiration. If implemented successfully, our proposed strategy can achieve significant cost savings for healthcare systems and blood suppliers. The proposed ordering strategy is generalizable to other blood products or even other perishable products.
△ Less
Submitted 17 August, 2020;
originally announced August 2020.
